BeAM (bedtime minus pre-breakfast glucose) in mg/dL from Zisman 2016. Provide bedtime_glucose_mg_dl or bedtime_glucose_mmol_l independently of AM, and am_glucose_mg_dl or am_glucose_mmol_l. mmol/L converts as mg/dL = mmol/L × 18. Returns beam_mg_dl (1 decimal) and the published analysis band (<0, 0-50, >50). 0 and 50 are 0-50. Does not use a 45 or 55 cutoff, order prandial insulin, or diagnose diabetes.

Sampson 2020 estimated LDL-C from total cholesterol, HDL, and triglycerides (valid through 800 mg/dL). One unit system (mg/dL or mmol/L). Deterministic published equation with citation; not Friedewald, not a diagnosis or statin order.

HOMA-IR as (fasting glucose in mmol/L × insulin in µU/mL) / 22.5 (Matthews et al. 1985). Provide glucose_mg_dl (50–1000) or glucose_mmol_l (2.8–55.5), not both; mg/dL converts as mmol/L = mg/dL / 18. Returns the approximation rounded to two decimals. Not HOMA-B, not the HOMA2 computer model, not a diabetes diagnosis, and not an insulin-resistance cutoff.

Ho 2004 day-3 IV-steroid score for severe UC (0–9): mean stools (<4 → 0; 4 ≤ x < 6 → 1; 6 ≤ x ≤ 9 → 2; x > 9 → 4), caller-assigned colonic dilatation (+4), albumin <30 g/L (+1; 30 is not low). Failure: 0–1 → 11%, 2–3 → 43%, ≥4 → 85% (ROC ≥4). Not Travis, not Truelove and Witts, not a colectomy order. magent does not count stools, read films, or measure albumin.

Simon Broome Register 1991 adult definite familial hypercholesterolaemia: total cholesterol >7.5 mmol/L or LDL cholesterol >4.9 mmol/L plus tendon xanthomas in the patient or a relative (parent, child, grandparent, sibling, uncle, or aunt). One lipid (mmol/L or mg/dL). magent does not assay lipids or examine tendons. Not a diagnosis, not possible FH, and not a DNA or child-cutoff classifier.

Nathan/ADAG A1C to estimated average glucose conversion, or the reverse. Provide exactly one of a1c_percent or eAG. Deterministic published equation with citation.

Dutch Lipid Clinic Network (Nordestgaard 2013 Table 1) familial hypercholesterolaemia score. One LDL (mmol/L or mg/dL / 38.67) plus family, clinical, physical, and DNA groups; per group only the highest. Max 26. Definite >8, probable 6-8, possible 3-5, unlikely 0-2. Score 8 (mutation alone) is probable. Adult Table 1 only; not Simon Broome, not MEDPED, not homozygous FH. magent does not assay lipids, examine tendons or arcus, or sequence genes. Not a medical device and not a diagnosis of FH.

Friedewald estimated LDL-C from total cholesterol, HDL, and triglycerides. One unit system (mg/dL or mmol/L). Deterministic published equation with citation; not a diagnosis or statin order.

Charles 2008 SMART-COP for intensive respiratory or vasopressor support in community-acquired pneumonia: SBP <90 (2), multilobar CXR (1), albumin <3.5 g/dL (1), age-adjusted RR (1), HR >=125 (1), new confusion (1), age-adjusted low oxygen (2), arterial pH <7.35 (2; omitted pH scores 0). Max 11. IRVS 0-2 low, 3-4 moderate, 5-6 high, >=7 very high. Not a site-of-care protocol. Albumin g/dL or g/L. Exactly one of PaO2, SpO2, or P/F.

Williams 1993 US MEDPED total cholesterol cutoffs by age and relative degree (first, second, third, or general population). Meets the published criterion iff total cholesterol in mg/dL is greater than the table cutoff (mmol/L converted as mg/dL = mmol/L * 38.67). Total cholesterol only; not Dutch Lipid Clinic or Simon Broome. Not a medical device and not a diagnosis of familial hypercholesterolemia.

Hegele 2025 NAFCS. Table 3 points from age or early HTG onset, BMI, abdominal pain or pancreatitis, secondary factors, fasting TG >880 mg/dL or >10 mmol/L, TG/TC >8 (mg/dL) or >3.5 (mmol/L), and apo B <1.0 g/L, plus published interactions. Max 100. ≥60 definite classical FCS; ≥45 very likely. Not a diagnosis or genetic test. Not Simon Broome or Dutch FH. magent does not examine the patient or assay lipids. Not a medical device.

Ranzani 2025 SOFA-2 from six organs 0-4 (brain, respiratory, cardiovascular, liver, kidney, hemostasis), max 24. Maps PaO2/FiO2 or SpO2/FiO2 with NIV/ECMO, MAP and vasopressor dose bands, caller-assigned GCS and delirium-drug flag, bilirubin, platelets, creatinine or urine rate, and RRT. Not Vincent 1996 SOFA and not a diagnosis.

Bello-Chavolla 2018 METS-IR: ln(2×glucose_mg_dl + triglycerides_mg_dl)×BMI / ln(HDL_mg_dl), natural log, two decimals. Supply glucose, triglycerides, and HDL each as exactly one of mg/dL or mmol/L (glucose ×18, TG ×88.57, HDL ×38.67). BMI is caller-supplied (10–80). highest_quartile_t2d is true only when METS-IR > 50.39 (derivation highest T2D-risk quartile). Not a diabetes diagnosis, not HOMA-IR/HOMA2, and not a treatment threshold.

Le Gall 1993 Simplified Acute Physiology Score II from 12 physiology variables (worst values in the first 24 hours as assigned by the caller), age, type of admission, and one chronic disease (AIDS, metastatic cancer, or hematologic malignancy). Max 163. Converts the integer to hospital-mortality probability with the paper's logit. PaO2/FiO2 is scored only if ventilated or CPAP. Not SAPS 3. Not APACHE. magent does not measure vitals.

Knight 2020 ISARIC 4C Mortality Score: age (<50→0, 50–59→2, 60–69→4, 70–79→6, ≥80→7) + male 1 + comorbidity_count (0/1/≥2 → 0/1/2; caller-assigned Charlson-plus-obesity count) + RR (<20→0, 20–29→1, ≥30→2) + room-air SpO2 (<92→2) + GCS (<15→2) + urea (<7→0, 7–14→1, >14→3 mmol/L; or BUN/2.8) + CRP (<50→0, 50–99→1, ≥100→2). Max 21. Table 5: low 0–3, intermediate 4–8, high 9–14, very high ≥15. Not a COVID-19 diagnosis or treatment order.

McGinnis 2024 VACS-CCI Table 2 Model 7 linear predictor from sex, age, hemoglobin, FIB-4, eGFR, albumin, WBC, BMI, hepatitis C, and caller-assigned Charlson groupings. CCI group is those weights (0/1/2/3+) times age band. The 0-100 score needs unpublished development min/max Xbeta; magent does not invent it. Paper prints score 30 to 1/3/8/18% and 45 to 6/14/35/61% at 1/2/5/10 years. Not a diagnosis or individual prognosis. magent does not code the chart.

Khorana 2008 Blood predictive model for chemotherapy-associated thrombosis: very_high site (stomach or pancreas) 2, high (lung, lymphoma, gynecologic, bladder, testicular) 1, other 0; platelets >=350 1; hemoglobin <10 g/dL or ESA 1 (once); WBC >11 x10^9/L 1; BMI>=35 caller flag 1. Max 6. 0 low; 1-2 intermediate; >=3 high. Not a diagnosis. Not Padua or Caprini. Caller assigns cancer site; magent does not compute BMI.

Caprini 2005 thrombosis risk assessment (Table 3): exclusive age (41-60=1, 61-74=2, >=75=3) and exclusive surgery (minor=1; arthroscopic/major/laparoscopic=2; arthroplasty=5) plus caller-assigned 1-, 2-, 3-, and 5-point flags. Max 78. Bands: 0-1 low, 2 moderate, 3-4 high, >=5 highest. Not a diagnosis. Not Caprini 2009/2013. Not a prophylaxis order.

LRINEC (Wong 2004): CRP ≥150 mg/L (4), WBC k/µL (<15 0, 15–25 1, >25 2), hemoglobin g/dL (>13.5 0, 11–13.5 1, <11 2), sodium <135 mmol/L (2), creatinine >141 µmol/L (2), glucose >10 mmol/L (1); max 13; cutoff ≥6. Deterministic published laboratory score with citation; not a diagnosis of necrotizing fasciitis and not an operative decision. A score below cutoff does not exclude disease.

Miller 2013 ATLAS for Clostridioides difficile: age (<60 0, 60–79 1, ≥80 2), systemic antibiotics during CDI therapy (0 or 2), WBC (<16 0, 16–25 1, >25 ×10^9/L 2), albumin (>35 0, 26–35 1, ≤25 g/L 2), creatinine (≤120 0, 121–179 1, ≥180 µmol/L 2); max 10. Predicted cure percent = 100 − 5.08 × score (1 decimal). Not a CDI diagnosis, stool culture, or metronidazole/vancomycin/fidaxomicin order.